Profil
Raju S.
Mohan was the founder of Akarna Therapeutics Ltd., founded in 2014, where the title held was Chief Executive Officer & Director from 2014 to 2016.
Dr. Mohan was the founder of Oppilan Pharma Ltd., founded in 2015, holding the title of Director from 2015 to 2021.
Dr. Mohan is the founder of Escalier Biosciences BV, founded in 2016, serving as Chief Executive Officer & Director since 2016.
Dr. Mohan was the founder of Vimalan Biosciences, Inc., founded in 2017, with the title Chief Executive Officer & Director.
Dr. Mohan is the founder of Zomagen Biosciences Ltd., founded in 2018.
Dr. Mohan was the founder of Ventyx Biosciences, Inc., founded in 2018, where the title held was President, Chief Executive Officer & Director from 2023 to 2026.
The current job is Partner & Senior Advisor at New Science Ventures LLC since 2017.
Former jobs include Vice President & Head-San Diego at Exelixis, Inc. from 2006 to 2011 and Vice President-Chemistry at X-Ceptor Therapeutics, Inc. from 2004 to 2006.
Education includes graduate studies at Indian Institute of Technology Bombay and a doctorate from the University of Illinois At Urbana–Champaign.
Postes actifs de Raju Mohan
| Sociétés | Poste | Début |
|---|---|---|
Escalier Biosciences BV
Escalier Biosciences BV BiotechnologyHealth Technology Develops biological products | Fondateur | 01/01/2016 |
Anciens postes connus de Raju Mohan
| Sociétés | Poste | Fin |
|---|---|---|
| VENTYX BIOSCIENCES, INC. | Fondateur | 04/03/2026 |
Oppilan Pharma Ltd.
Oppilan Pharma Ltd. BiotechnologyHealth Technology Provides research and development on biotechnology services | Fondateur | 01/02/2021 |
Zomagen Biosciences Ltd. | Fondateur | 01/02/2021 |
Akarna Therapeutics Ltd.
Akarna Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Develops novel small molecule therapeutics | Fondateur | 01/09/2016 |
| EXELIXIS, INC. | Corporate Officer/Principal | 01/01/2011 |
Formation de Raju Mohan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Exelixis, Inc.
Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
X-Ceptor Therapeutics, Inc.
X-Ceptor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research and development of small molecule therapeutics | Commercial Services |
New Science Ventures LLC
New Science Ventures LLC Investment ManagersFinance New Science Ventures invests in companies located in the United States. The firm focuses on information technology and life sciences sectors. It provides financing for early and later stage capital requirements. It also acts as a lead investor. | Finance |
Indian Institute of Technology Bombay
Indian Institute of Technology Bombay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akarna Therapeutics Ltd.
Akarna Therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Develops novel small molecule therapeutics | Health Technology |
Oppilan Pharma Ltd.
Oppilan Pharma Ltd. BiotechnologyHealth Technology Provides research and development on biotechnology services | Health Technology |
Escalier Biosciences BV
Escalier Biosciences BV BiotechnologyHealth Technology Develops biological products | Health Technology |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Zomagen Biosciences Ltd. | |
Vimalan Biosciences, Inc.
Vimalan Biosciences, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory diseases and autoimmune disorders | Health Technology |
















